Therapeutic Significance of D-dimer Cut-off Level of more than 3 µg/ml in Colorectal Cancer Patients Treated with Standard Chemotherapy plus Bevacizumab.
NCCHE
CRC Tissue Core FISH initiative/Cytogenetics Team Mayo:OSU: Dan Van DykeNyla Heerema Neil KayJohn Byrd Stephanie SmoleyCarlo Croce (P1) Jeanette Passow.
Mts epatiche - Roma 20071 Optimal Management of Liver Metastases: Present Results and Future Strategies Highlights in the Management of CRC Roma, 1-2 febbraio.